Delivered Capacity Drives the Quarter

Core Scientific reported third-quarter revenue of $232.9 million in its November 5 earnings release, including $215.4 million from high-density colocation. The company said it was billing for 485 megawatts of capacity at September 30. The results show colocation accounting for the clear majority of its current revenue.

The company's reported net income was approximately $1.18 billion, helped by a non-cash gain from changes in the fair value of warrants. Adjusted EBITDA was $133.6 million. Those measures describe different aspects of performance, and the large accounting gain should not be treated as an equivalent amount of operating cash generated.

Revenue Mix Makes the Transition Visible

A business can announce a change in strategy well before that change becomes visible in its income statement. In this quarter, the contribution from colocation provides evidence of delivered activity rather than only a pipeline of future projects. The billing capacity figure adds an operational measure alongside the financial result.

Mining and colocation have different revenue drivers. Mining depends on producing digital assets under changing network and market conditions. Colocation involves providing infrastructure to customers under commercial arrangements. Moving between those models can alter the importance of construction schedules, customer concentration and contracted service obligations when interpreting the business.

Investment Requirements Remain Substantial

Core Scientific reported approximately $985.1 million in capital expenditures for the quarter. The company is continuing construction and says it is repurposing remaining mining facilities for colocation as circumstances allow. These figures show that a stronger revenue contribution can coexist with substantial spending to build the next stage of capacity.

For readers following the transition, delivered capacity and cash requirements need to be assessed together. A completed facility can begin contributing revenue while another site consumes funds during development. Annualized revenue measures can offer a useful indication of scale, but they are not the same as revenue already recognized over a full year.

The quarter provides a concrete picture of Core Scientific's changing business: colocation is now the dominant reported revenue source, supported by a growing billing footprint. The next questions concern continued delivery, recurring profitability and the funding of expansion. Separating operating progress from non-cash accounting movements makes those developments easier to evaluate.